A61K 40/4532
Staphylococcus
Official title: {Staphylococcus}
A61K40/4532 (Staphylococcus) appears on 14 US grants and 18 published applications in this corpus.
Search patents in A61K- Granted patents
- 14
- Published applications
- 18
- Assignees
- 13
- Inventors
- 38
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 3 |
| 2020 | 2 | 0 |
| 2021 | 1 | 3 |
| 2022 | 0 | 3 |
| 2023 | 0 | 0 |
| 2024 | 3 | 2 |
| 2025 | 1 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for treating HIV infection and reversing HIV latency6 Jan 2026US 12,514,921 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Monocyte compositions and methods for the treatment of infectious disease14 Jan 2025US 12,193,996 B2President and Fellows of Harvard College
- Target-primed macrophages and therapeutic uses thereof15 Oct 2024US 12,116,595 B2Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Methods for the long-term expansion of granulocyte-macrophage progenitors and applications thereof11 Jun 2024US 12,006,513 B2University of Southern California
- Compositions and methods for modified b cells expressing reassigned biological agents28 May 2024US 11,993,646 B2Kota Biotherapeutics, LLC
- Methods for the long-term expansion of granulocyte-macrophage progenitors and applications thereof5 Sep 2024US 2024/0294873 A1University of Southern California
- Methods for the expansion of human granulocyte-macrophage progenitors and applications thereof5 Sep 2024US 2024/0294876 A1University of Southern California
- Compositions and methods for detecting hiv latency, treating hiv infection, and reversing hiv latency11 Aug 2022US 2022/0249653 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Monocyte compositions and methods for the treatment of infectious disease30 Jun 2022US 2022/0202855 A1President and Fellows of Harvard College
- Target-primed macrophages and therapeutic uses thereof3 Feb 2022US 2022/0033777 A1Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Most cited
By later US patents
- Method of cancer treatment48US 5,728,388 A1998
- Method of cancer treatment39US 6,251,385 B12001
- Method of cancer treatment14US 6,180,097 B22001
- Compositions and methods including cytotoxic B lymphocyte cell line expressing exogenous membrane immunoglobulin different from secreted immunoglobulin2US 10,233,424 B2Elwha LLC · 2019
- Compositions and methods for modified B cells expressing reassigned biological agents2US 10,597,442 B2Kota Biotherapeutics, LLC · 2020